Skip to main content
Fig. 6 | Molecular Medicine

Fig. 6

From: Protection Against Hyperacute Xenograft Rejection of Transgenic Rat Hearts Expressing Human Decay Accelerating Factor (DAF) Transplanted into Primates

Fig. 6

FACS analysis of in vitro human complement deposition on wild-type versus transgenic rat ECs. Cardiac endothelial cells were isolated from wild-type (dotted line) and transgenic, either DAF+/− hemizygous (plain line) or DAF+/+ homozygous (bold line), rats. Immunostaining was performed on ECs incubated with human serum (dilution 1/10) for 30 min at 37°C. After incubation, ECs were washed and then incubated with either an FITC-labeled anti-human C3, C4, or factor B MAb or with an anti-human C5b-9 polyclonal rabbit serum followed by an FITC-labeled anti-rabbit Ab.

Back to article page